Orbital vascular lesions encompass a spectrum of rare, heterogeneous pathologies that can present with varying clinical manifestations.The four cases described in our case series are: one 14-year-old boy with gradually progressive unilateral proptosis diagnosed as orbital hemangioma, one3-year-old child with bilateral anophththalmos and lid swelling diagnosed asorbital lymphangioma, one 47-year-old lady with gradually growing medial canthal mass diagnosed as hemangioma, and lastly, one 8-year-old boy with unilateral lid swelling diagnosed asorbital hemangioma. All patients were thoroughly examined clinically and diagnoses were confirmed radiologically. All patients demonstrated significant clinical improvement followingsclerotherapy. The treatment was well-tolerated, with no major complications noted. Cosmetic outcomes were favourable, with a reduction in lesion size on follow up visits. The cases presented illustrate the versatility and safety of sclerotherapy as an effective and minimally invasive therapeutic option for the management of orbital vascular lesions across a variety of pathologies, emphasizing its potential as a first-line treatment in carefully selected patients.